ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,020.26
-0.31%
Dow Jones
37,935.65
0.32%
US Dollar vs MXN
17.02406
-0.75%
Brent Oil
83.795
-2.44%
Bitcoin
56,911.47
-6.09%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Deciphera Pharmaceuticals Inc (DCPH)

  7. Deciphera Pharmaceuticals Inc (DCPH) Noticias

DCPH Deciphera Pharmaceuticals Inc

25.31
0.04 (0.16%)
Última actualización: 11:32:46
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Deciphera Pharmaceuticals Inc DCPH NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.04 0.16% 25.31 11:32:46
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
25.29 25.27 25.36 25.27
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202406:00BWDeciphera Pharmaceuticals to be Acquired by ONO..
09/4/202406:00BWDeciphera Pharmaceuticals to Present at the Stifel 2024..
27/2/202406:00BWDeciphera Pharmaceuticals to Participate in Upcoming..
20/2/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202415:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202415:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202406:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/2/202406:11EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/2/202406:10EDGAR2Form 8-K - Current report
06/2/202406:00BWDeciphera Pharmaceuticals Announces Fourth Quarter and Full..
01/2/202415:50BWDeciphera Pharmaceuticals to Announce Fourth Quarter and..
01/2/202406:00BWDeciphera Pharmaceuticals to Present at the Guggenheim..
18/1/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202410:13BWDeciphera Pharmaceuticals Presents Long-Term Follow-Up..
08/1/202406:14EDGAR2Form 8-K - Current report
08/1/202406:00BWDeciphera Pharmaceuticals Announces Planned 2024 Corporate..
05/1/202406:00BWDeciphera Pharmaceuticals Announces Nature Medicine..
02/1/202406:00BWDeciphera Pharmaceuticals to Present at the 42nd Annual J.P...
14/12/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202317:05EDGAR2Form 144 - Report of proposed sale of securities
29/11/202306:00BWDeciphera Pharmaceuticals to Present at the JMP Securities..
07/11/202306:00BWDeciphera Pharmaceuticals to Participate in Upcoming..
31/10/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202306:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/10/202306:06EDGAR2Form 8-K - Current report
30/10/202306:01BWDeciphera Pharmaceuticals Announces Third Quarter 2023..
30/10/202306:00BWDeciphera Pharmaceuticals Announces Positive Top-line..
29/9/202308:00PRNUSMedison Pharma Announces Public Formulary Listing of..
19/9/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202316:00BWDeciphera Pharmaceuticals, Inc. Announces Inducement Grants..
05/9/202315:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/8/202315:05BWDeciphera Pharmaceuticals, Inc. Announces Inducement Grants..
09/8/202306:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202306:06EDGAR2Form 8-K - Current report
09/8/202306:00BWDeciphera Pharmaceuticals Announces Second Quarter 2023..
03/8/202315:20EDGAR2Form 8-K - Current report
03/8/202315:15BWDeciphera Pharmaceuticals Announces Retirement of Daniel L...
02/8/202306:00BWDeciphera Pharmaceuticals to Announce Second Quarter 2023..
25/5/202316:00BWDeciphera Pharmaceuticals to Present Data from INTRIGUE..
23/5/202306:00BWDeciphera Pharmaceuticals to Participate in Upcoming..
08/5/202306:00BWDeciphera Pharmaceuticals to Present at the JMP Securities..

Su Consulta Reciente

NASDAQ
DCPH
Deciphera Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados